An iterative cross-coupling based approach to the synthesis of peridinin and progress towards peridinin derivatives by Davis, Erin
 
 
 
 
 
AN ITERATIVE CROSS-COUPLING BASED APPROACH TO THE SYNTHESIS OF 
PERIDININ AND PROGRESS TOWARDS PERIDININ DERIVATIVES 
 
 
 
 
 
 
 
 
 
 
BY 
 
 
ERIN KATHLEEN DAVIS 
 
 
 
 
 
 
 
 
 
 
 
THESIS 
 
 
Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Chemistry in 
the Graduate College of the 
University of Illinois at Urbana-Champaign, 2013 
 
 
 
Urbana, Illinois 
 
 
 
Adviser: 
 
 
Professor Martin D. Burke 
ii 
 
 
   
 
 
 
 
 
  
 
 
 
Abstract 
 
Lipoperoxidation plays a role in diseases such as atherosclerosis, rheumatoid arthritis, 
cancer, and may contribute to the general phenomenon of aging. As individuals with deficiencies 
of antioxidant proteins are particularly susceptible to these diseases, small molecules with the 
ability to act as antilipoperoxidants have the potential to serve as powerful pharmaceuticals. 
Peridinin (2), an atypical carotenoid found in dinoflagellates responsible for the color of red tide, 
is especially interesting as a potential antilipoperoxidant because it may act through self- 
preserving mechanisms, unlike other carotenoids. We report the total synthesis of the protected 
form of a peridinin derivative lacking the butenolide functionality and contributions towards the 
development of a stereoretentive Suzuki-Miyaura coupling of haloallenes. 
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CHAPTER 1 
 
CAROTENOIDS IN NATURE AND HUMAN HEALTH 
 
 
1-1 INTRODUCTION 
 
Lipoperoxidation plays a role in diseases such as atherosclerosis, rheumatoid arthritis, 
cancer,  and  may  contribute  to  the  general  phenomenon  of  aging.1   As  individuals  with 
deficiencies  of  antioxidant  proteins  are  particularly  susceptible  to  these  diseases,2   small 
molecules with the ability to act as antilipoperoxidants have the potential to serve as powerful 
pharmaceuticals.  Carotenoids have long been thought to have antioxidant properties, but their 
specific mechanism  of action  remains  unknown.  Peridinin3   an  atypical  carotenoid  found in 
 
dinoflagellates responsible for the color of red tides, is especially interesting as a potential 
antilipoperoxidant because it may act through self-preserving mechanisms,4 unlike other 
carotenoids.  In dinoflagellates, peridinin is housed in the peridinin-chlorophyll-protein (PCP) 
complex, where it serves as a light harvester, as well as protects the PCP through catalytic 1O2 
quenching.  Due to inefficient isolation from natural sources and the challenge of synthesizing 
peridinin  in  a  stereoselective  manner,  its  activity  as  an  antilipoperoxidant  has  only  been 
minimally studied. Recent results from our group show that peridinin is in fact a superior 
antilipoperoxidant in liposome-based assays. Peridinin derivatives have been studied in the 
context of their photosynthetic activity,5 but not their ability to quench 1O2 or other reactive 
oxygen species.  In order to figure out how nature evolved peridinin to be an excellent quencher 
of 1O2, we have proposed to employ our stereocontrolled, efficient, and modular synthesis6  to 
retrosynthesize four derivatives that correspond to reversal of the four tailoring enzyme 
modifications occurring on the biosynthetic pathway. Synthesizing derivatives of peridinin will 
also allow for the investigation of the structure-function relationship that lie at the heart of its 
superior antilipoperoxidant ability. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Tailoring enzyme modifications in the biosynthesis of peridinin. 
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1-2 LIPOPEROXIDATION IN HUMAN DISEASE 
 
The inflammatory response is important to human health because it defends against 
invading pathogens. However, chronic inflammation contributes to several diseases, including 
cancer, cardiovascular diseases, and rheumatoid arthritis. One part of chronic inflammation is 
lipid peroxidation, which has been specifically implicated in several diseases. During the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Lipoperoxidation creates harmful breakdown products. 
 
lipoperoxidation process, polyunsaturated fatty acids (PUFAs) are oxidized by reactive oxygen 
species. This oxidation process results in both the destruction of the PUFA and the formation of 
harmful oxidation products, including malondialdehyde (MDA) and 4-hydroxynonenal (HNE). 
Furthermore, it has been shown that the radical cascades involves in lipid peroxidation can have 
very long chain lengths. For instance, it has been estimated that 200 molecules of 20:4 lipid can 
be oxidized per initial oxidation event.7  The body does have defenses against reactive oxygen 
species and the products of lipid peroxidation, but under conditions of high oxidative stress or 
when individuals have mutations leading to a loss of function in such an enzyme, these defenses 
can be overwhelmed. 
 
Atherosclerosis 
 
Atherosclerosis occurs when the walls of arteries thicken due to a build-up of fatty 
materials, such as cholesterol and triglycerides. These plaques can rupture, causing heart attacks 
or strokes. Recent research has shown that oxidized phospholipids play an important role 
atherosclerosis.  It  is  well-known  that  dangerous  LDL  cholesterol  contains  oxidized 
phospholipids. Some oxidized phospholipids are known to promote monocyte adhesion to 
endothelial cells and increase kinase activation and angiogenesis, all of which are factors that 
promote  angiogenesis.8   One  example  is  oxidized  palmitoyl  arachidonyl  phosphatidylcholine 
3  
 
 
(Ox-PAPC), which is known to accumulate in atherosclerotic plaques, have proatherogenic 
effects, and also influences the expression of over 1000 genes in human endothelial cells.9 
Cancer 
 
Breakdown products formed from the lipoperoxidation process can go on to react with 
biological molecules, including amino acid side chains in proteins and DNA.10 For example, 
MDA is a known mutagen and carcinogen. MDA can either react with DNA as a single molecule 
or react with itself to form oligomers before going on to react with DNA, creating several 
possible DNA adducts (Figure 1.2).11 Work by Marnett and coworkers has shown that these 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 DNA adducts formed by MDA and MDA oligomers. 
 
adducts do lead to mutations.12  Specifically, a representative plasmid was directly reacted with 
MDA and the plasmid was then replicated in E. coli, and mutations were then identified and 
sequenced. The results showed that guanine residues were mutated to thymine, adenine residues 
were mutated to guanine, and cytosine residues were mutated to thymine. Mutations caused by 
4  
the reaction of other electrophiles, including HNE with DNA have been also characterized.13 
 
Over time, the buildup of such mutations can result in cancer. 
 
 
1-3 CAROTENOIDS IN NATURE 
 
Naturally occurring carotenoids are found mostly in light harvesting complexes, where 
they perform a dual role in photoprotection and light harvesting. As light harvesters, carotenoids 
are  able  to  expand  the  range  of  light  wavelengths  that  plants  can  absorb  and  are  able  to 
efficiently transfer this light energy. The triplet state of chlorophyll is known to be a potent 
sensitizer for the formation of reactive singlet oxygen. As photoprotectors, carotenoids are able 
to quench both triplet chlorophyll before it forms singlet oxygen and singlet oxygen itself. 
Because of this interesting dual function, carotenoids have been extensively studied with regard 
to photosynthesis. 
Light harvesting 
 
Light harvesting complexes, such as the peridinin-chlorophyll protein (PCP) complex, are 
able  to  hold  carotenoid  and  chlorophyll  molecules  in  an  optimal  configuration  for  energy 
transfer.   Several interactions and energy pathways are responsible for the transfer of energy 
from the carotenoid to chlorophyll and can determine the rate and efficiency with which energy 
is transferred.14  The three main factors are the electronic coupling between the carotenoid and 
chlorophyll, the energetic overlap of the acceptor absorbance and donor emission spectra, and 
how long the excited donor state lasts in the absence of energy transfer.15  The structure of the 
carotenoid plays a role in all of these factors, raising the question of which structural motifs are 
most important in creating an efficient light harvester. 
Some light-harvesting complexes, including the PCP, have been found to utilize an 
intramolecular charge transfer (ICT) state to enhance energy transfer efficiency. Through a series 
of spectroscopic studies on the PCP complex, Polivka and coworkers16 found that in contrast to 
higher plants, which primarily use the S2  carotenoid-Chl transfer pathway, the PCP uses an 
S1/ICT  carotenoid-Chl  pathway.1,2   This  pathway  allows  for  an  increase  in  the  amount  of 
absorbed energy that can be transferred to the chlorophyll reaction center. Both the unique 
 
structure of peridinin and the specifically-tuned polarity of the environment around it are thought 
to be responsible for the ability to form an ICT state. 
5  
Photoprotection 
 
Plants and other photosynthetic organisms are exposed to widely varying amounts of 
sunlight during a single day. Under low light conditions, nearly all the captured photons are used 
in the reactions of photosynthesis. On the other hand, when plants face conditions of high light 
intensity, the photosynthetic apparatus must be protected. Conditions of high intensity lead to the 
generation of reactive oxygen species and the destruction of the proteins involved in 
photosynthesis. Non-photochemical quenching of chlorophyll fluorescence has been identified as 
a  mechanism  of  photoprotective  energy  dissipation.17   In  the  process  of  non-photochemical 
 
quenching, potentially harmful energy is dissipated as heat. Walla and coworkers have proposed 
the idea of light- and dark-adapted carotenoid complexes.18 In their work, light-adapted systems 
showed a greater carotenoid-chlorophyll coupling, allowing for energy to be delocalized over 
both molecules and then dissipated. The polarity of their environments, as well as carotenoids 
themselves, is an important factor in coupling to chlorophyll, making polar carotenoids like 
peridinin interesting targets for studying photoprotective ability and the role carotenoid structure 
plays therein. 
 
1-4 CAROTENOIDS AS ANTIOXIDANTS 
 
Considering their known antioxidant properties in photosynthetic organisms, carotenoids 
would seem to be promising antioxidants in the context of human health.  Early epidemiological 
studies showed that individuals with an above-average consumption of beta-carotene had a lower 
than average risk of developing cancer.19  Laboratory studies showed that beta-carotene was a 
competent radical-trapping antioxidant at physiologically relevant oxygen pressures.20 These 
results led to the initiation of several intervention studies, notably the Alpha-Tocopherol Beta- 
Carotene Prevention Trial (ABTC) and the Beta-Carotene and Retinol Efficacy Trial (CARET). 
 
In the ABTC trial, over 29,000 male smokers were given either alpha-tocopherol, beta- 
carotene, both or a placebo. Follow-up was conducted for 5-8 years. The study showed a 16% 
increase in  the incidence of lung cancer in  the group that  was  taking  beta-carotene.21   The 
CARET study looked at the impact of dual beta-carotene and retinol supplementation in both 
men and women at higher risk for lung cancer versus placebo. The trial was stopped after 21 
months early because the intervention group showed a 28% increase in the incidence of lung 
cancer and 17% more deaths than the group taking the placebo.22 
6  
The failure of these intervention studies highlights the need to understand the mechanism 
of carotenoid antioxidant activity. Since that time, several smaller studies using carotenoids have 
been published. A study performed in Finland investigated the effect of three-month astaxanthin 
supplementation on lipid peroxidation healthy non-smoking males.23  The group taking 
astaxanthin showed lower plasma levels of 12- and 15-hydoxy fatty acids than the placebo 
group. Another study examined the role of astaxanthin in ischemia-reperfusion injury in rats.24 
Injecting rats with either astaxanthin or vehicle prior to cutting off blood flow to the brain 
showed a decrease in ischemic brain injury.  Although such studies indicate that carotenoids may 
be able to play a role in preventing or treating certain disease states, they have not provided any 
insight into the mechanism of antioxidant function. 
 
1-5 SUMMARY 
 
Although  carotenoids  are  known  for  their  antioxidant  properties  in  photosynthetic 
systems and carotenoids such as astaxanthin are touted as excellent antioxidants, little is known 
about the mechanism of their antioxidant activity. Peridinin is a promising antilipoperoxidant 
due to its self-preserving mechanism. Due to inefficient isolation from natural sources and the 
challenge of synthesizing peridinin in a stereoselective manner, its activity as an 
antilipoperoxidant has only been minimally studied.   In order to more fully understand its 
antilipoperoxidant behavior and also to discern what functional group are in important in 
antioxidant activity, we have proposed to employ our stereocontrolled, efficient, and modular 
synthesis25 of peridinin in the synthesis of four derivatives of peridinin, each corresponding to a 
 
reversal of a tailoring enzyme modification in peridinin’s biosynthetic pathway (Scheme 1.1). 
Progress towards the synthesis of two peridinin derivatives are described herein. 
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CHAPTER 2 
 
DEVELOPMENT OF THE STEREORETENTIVE SUZUKI-MIYAURA COUPLING OF 
HALOALLENES 
 
2-1 INTRODUCTION 
The major challenge in the synthesis of peridinin (2.1) and other allene-containing 
carotenoids lies in the stereocontrolled construction of the polyene core, particularly the allene 
functionality. Previous syntheses of 2.1 have relied on olefinations such as the Julia olefination 
and  have  led  to  mixtures  of  stereoisomers  rather  than  the  desired  all-trans  isomer.1   These 
mixtures required either isomerization processes or tedious separations in order to isolate 2.1 as a 
pure compound. Due to the difficulties in synthesizing 2.1, along with inefficient isolation from 
natural sources, its biological and antioxidant activity has been largely unstudied. In order to 
effectively study its antilipoperoxidant activity, a flexible and scalable synthesis of 2.1 needed to 
be developed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Retrosynthetic analysis of peridinin (2.1). 
 
Previous work in the group had demonstrated the efficacy of the iterative cross-coupling 
(ICC) approach to small molecule synthesis using the Suzuki-Miyaura (SM) reaction.2 This 
platform features the use of bifunctional haloboronic acids that have the boronic acid masked by 
an N-methyliminodiacetic acid protecting group. The retrosynthesis of 2.1 followed this 
precedent, using only SM transforms to retrosynthesize the molecule. Thus, 2.1 was broken into 
four building blocks, as shown in Figure 2.1. Eric Woerly developed scalable routes to each 
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building block, allowing access to large amounts of material. The realization of such as modular 
synthesis also gives excellent flexibility. Replacing one building block with another—for 
example, replacing allenyl iodide 3.5 with a vinyl iodide—would give a derivative that differs by 
only one functional group without any other changes to the synthesis of the molecule. This 
flexibility would allow for structure-function studies that will contribute to a greater 
understanding of peridinin’s antilipoperoxidant activity and may also help to further our 
knowledge of lipoperoxidation itself. The hurdle that remained was the construction of the allene 
functionality in a stereocontrolled manner. Stereoretentive SM coupling of unactivated 
haloallenes was an unknown transformation at the time and one that could prove useful in the 
synthesis of other natural products.3 
 
Herein, we describe the development of a stereoretentive Suzuki-Miyaura coupling of 
chiral, unactivated haloallenes, which enabled the synthesis of 2.1 in a stereocontrolled fashion. 
Work in this chapter was done in collaboration with Eric Woerly and Alan Cherney. 
 
2-2 BACKGROUND ON ALLENE COUPLINGS 
 
In order to synthesize both peridinin and several of its derivatives, the stereocontrolled 
Suzuki-Miyaura (SM) reaction of chiral haloallenes needed to be realized. Although there were 
examples in the literature of SM coupling of haloallenes,4  these examples were of nonchiral or 
racemic starting materials and therefore no information about the stereooutcome of the reaction 
could be gained. 
 
 
 
 
 
 
 
Figure 2.2. Previous examples of SM coupling of haloallenes. 
 
However, Negishi couplings of chiral, unactivated haloallenes were known. These 
couplings were gave inversion of configuration for chloro- and bromoallenes, while retention of 
configuration is observed for iodoallenes.5 These results were thought be caused by the existence 
of two competing pathways for the oxidative addition of palladium into a haloallene—direct 
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oxidative addition and oxidative addition via an SN2 mechanism followed by a suprafacial shift 
 
of Pd and completion of the catalytic cycle, as shown in Figure 2.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Direct oxidative addition results in retention of configuration, while indirect oxidative addition results in 
stereoinversion. 
 
Work in our group5  had shown that the reaction of PhB(OH)2  with enantiomerically enriched 
haloallenes resulted in net stereoinversion in the case of chloro- and bromoallenes (Table 1, 
entries 1-2), while the iodoallene gave retention of configuration in the product (entry 3). These 
results led us to more carefully examine the parameters around allene coupling, allowing us to 
establish a set of rules for stereoretentive coupling of allenes. 
 
2-3 DEVELOPMENT OF COUPLING METHODOLOGY 
 
Synthesis of Haloallenes 
 
A series of iodoallenes with decreasing steric bulk was synthesized to test the hypothesis 
that steric bulk at C3 is required for the stereoretentive coupling of haloallenes. Allenes were 
synthesized as outlined in Scheme 3. Addition of bis(TMS)-acetylene 2.6 to the corresponding 
acid chloride 2.7 under Friedel-Crafts conditions gave the ketones 2.8 in yields ranging from 69- 
90%.   Noyori transfer hydrogenation followed by removal of the trimethylsilyl group and 
treatment with mesyl chloride produced mesylates 2.11 in high e.r.  (99.0:1.0 in all cases). 
Refluxing in THF with the appropriate lithium and copper halides gave haloallenes 2.12a-e.5 
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Scheme 2.1 Synthesis of haloallene substrates. 
 
Development of Coupling Methodology 
 
As shown in Table 1 entries 3-5, decreasing steric bulk at C3 resulted in a decrease in 
percent stereoretention.   Since steric bulk of the substrate was thought to result in direct 
OA being favored, we hypothesized that the use of bulky phosphine ligands would also 
promote direct OA at the less sterically hindered C1.  Smaller ligands resulted in percent 
stereoretentions ranging  from  50-80  (entries  3,  6-8),  while  ligands  with  cone  
angles  >180  gave  >90% stereoretention.  Together, these findings showed that maximized 
stereoretention in the SM coupling of chiral haloallenes can best be achieved using allenyl 
iodide substrates with steric bulk at C3 in combination with sterically bulky phosphine ligands.  
This methodology was then applied to the final coupling in the synthesis of 2.1. 
 
 
Table 2.1 Development of Haloallene Coupling Methodology 
 
 
 
 
 
 
 
entry 12 R X ligand 13 % stereoretentiona,b 
1 (R)-2.12a t-Bu Cl PPh3 (S)-2.13a -79 
2 (R)-2.12b t-Bu Br PPh3 (S)-2.13a -78 
3 (R)-2.12c t-Bu I PPh3 (R)-2.13a 72 
4 (R)-2.12d 3-pentyl I PPh3 (R)-2.13b 58 
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Table 2.1 (cont.) 
 
5 (R)-2.12e n-pentyl I PPh3 (R)-2.13c 25 
6 (R)-2.12c t-Bu I PFur3 (R)-2.13a 80 
7 (R)-2.12c t-Bu I PCy3 (R)-2.13a 50 
8 (R)-2.12c t-Bu I Pt-Bu2Me (R)-2.13a 71 
9 (R)-2.12c t-Bu I Po-Tol3 (R)-2.13a 91 
10 (R)-2.12c t-Bu I Pt-Bu3 (R)-2.13a 93 
11 (R)-2.12c t-Bu I XPhos (R)-2.13a 91 
12c (R)-2.12c t-Bu I XPhos (R)-2.13a >99 
13c (R)-2.12d 3-pentyl I XPhos (R)-2.13b >99 
14c (R)-2.12e n-pentyl I XPhos (R)-2.13c 85 
a % stereoretention ) ee product/ee starting material (chiral GC, average of 2 runs); negative values 
reflect net stereoinversion.b Unoptimized GC yields ranged from 10 to 83%. c Hexane:THF:H2O 
9:1:1 was used as solvent. 
 
 
2-4 SUMMARY 
 
The results above demonstrate the stereoretentive SM coupling of chiral, unactivated 
haloallenes. The key factors in achieving stereoretention were found to be the steric bulk of the 
ligand, steric bulk at C3 and use of iodide as the halide, and to a lesser extent, the use of a 
nonpolar solvent. These principles were used to design the final coupling in the synthesis of 2.1. 
First, an iodide was used as the halide when building block 2.5 was synthesized. Secondly, the 
alcohol adjacent to the iodoallene was protected with a TMS group, providing steric bulk. A 
catalyst system similar to the model system was also used, with XPhos as the ligand. Thus, when 
the final coupling was performed by Eric Woerly, the result was complete stereoretention. The 
development of a set of principles for the coupling of chiral, unactivated haloallenes was crucial 
in the establishment of an iterative Suzuki-Miyaura coupling approach to the synthesis of 
peridinin. With this well-developed method in hand, we turned our attention to the synthesis of 
the targeted peridinin derivatives that contain this motif. 
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2-6 EXPERIMENTAL INFORMATION 
 
Supporting Information 
 
Part A 
 
 
I. General methods S1-S2 
II. Experimental procedures S3-S9 
 
 
I. General methods 
 
 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa 
Aesar, TCI America, Strem Chemicals Inc., or Frontier Scientific and were used without further 
purification unless otherwise noted. Solvents were purified via passage through packed columns 
as described by Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; 
hexane, benzene, and toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves). All water was deionized prior to use. Triethylamine, diisopropylamine, 
pyridine, and 2,6-lutidine were freshly distilled under an atmosphere of nitrogen from CaH2. The 
following compounds were prepared according to known literature procedures: haloallenes 2.12.2 
 
General Experimental Procedures. Unless noted, all reactions were performed in flame-dried 
round bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of 
argon or nitrogen. Organic solutions were concentrated via rotary evaporation under reduced 
pressure with a bath temperature of 35 – 40 oC.  Reactions were monitored by analytical thin 
layer chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 nm) 
and/or a solution of basic KMnO4 followed by brief heating using a Varitemp heat gun.  MIDA 
boronates are compatible with standard silica gel chromatography, including standard loading 
techniques.  Column chromatography was performed using standard methods3 or on a Teledyne- 
Isco CombiFlash Rf purification system using Merck silica gel grade 9385 60Å (230-400 mesh). 
For loading, compounds were adsorbed onto non acid-washed Celite in vacuo from an acetone 
solution.   Specifically, for a 1 g mixture of crude material the sample is dissolved in reagent 
grade acetone (25 to 50 mL) and to the flask is added Celite 454 Filter Aid (5 to 15 g). The 
mixture is then concentrated in vacuo to afford a powder, which is then loaded on top of a silica 
gel column. The procedure is typically repeated with a small amount of acetone (5 mL) and 
Celite (2 g) to ensure quantitative transfer. 
 
Structural analysis. 1H NMR spectra were recorded at 23 °C on one of the following 
instruments: Varian Unity 400, Varian Unity 500, Varian Unity Inova 500NB. Chemical shifts 
(δ) are reported in parts per million (ppm) downfield from tetramethylsilane and referenced to 
residual protium in the NMR solvent (CHCl3, δ = 7.26; acetone-d6, δ = 2.05, center line) or to 
added tetramethylsilane (δ = 0.00). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sext = sextet, sept = septet, m = 
 
1 Pangborn, A.B.; Giardello, M.A; Grubbs, R.H.; Rosen, R.K.; Timmers, F.J. Organometallics 1996, 15, 1518. 
2 Elsevier, C.J.; Vermeer, P.; Gedanken, A.; Runge, W. J. Org. Chem. 1985, 50, 364. 
3 Still, W.C.; Kahn, M.; Mitra, A.; J. Org. Chem. 1978, 43, 2923. 
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multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), and integration. 13C 
NMR spectra were recorded at 23 °C on a Varian Unity 400 or Varian Unity 500. Chemical 
shifts (δ) are reported in ppm downfield from tetramethylsilane and referenced to carbon 
resonances in the NMR solvent (CDCl3, δ = 77.0, center line; center line; acetone-d6, δ = 29.80, 
center line). High resolution mass spectra (HRMS) were performed by Furong Sun and Beth 
Eves at the University of Illinois School of Chemical Sciences Mass Spectrometry Laboratory. 
Specific rotations were measured on a Jasco DIP-370 Digital Polarimeter.  Gas chromatography 
analysis was conducted on an Agilent Technologies 7890A instrument.  GC yields are based on a 
dodecane internal standard using an Agilent Technologies HP-5 column (part number 19091J- 
413).  The stereoretention values were determined by GC analysis with an Agilent Technologies 
chiral β-cyclodextrin stationary phase (part number 112-2532). 
 
 
Synthesis of Haloallenes 12a-e. 
The general reaction scheme for the synthesis of haloallenes 12a-e is shown below and reaction 
references are provided (Figure 2.4):4, 5, 6, 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  Synthesis of haloallenes 2.12 a-e 
 
 
 
 
 
 
 
 
 
General procedure for the synthesis of haloallenes 2.12a-e.3 
 
Preparation of LiCuX2: 
 
 
 
 
4 Representative procedure: Bach, J.; Berenguer, R.; Garcia, J.; Loscertales, T.; Vilarrasa, J. J. Org. Chem. 1996, 61, 9021. 
5 Representative procedure: Matsumura, K.; Hashiguchi, S.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1997, 119, 8738. 
6 Representative procedure: Fouad, F.S.; Wright, J.M.; Plourde, G.; Purohit, A.D.; Wyatt, J.K.; El-Shafey, A.; Hynd, G.; Crasto, 
C.F.; Lin, Y.; Jones, G.B. J. Org. Chem. 2005, 70, 9789. 
7 Westmijze, H.; Vermeer, P. Synthesis 1979, 390. 
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The purity of copper (I) iodide was found to be critical to the enantiopurity of the products 2.12c- 
e. High purity (>99.999%) copper (I) iodide was purchased from Strem or prepared by 
recrystallization.8 
 
In a glovebox, to a Schlenk flask equipped with a stir bar and charged with copper (I) halide (4 eq) 
was added THF (6 M with respect to the copper halide).  Lithium halide (2 eq) and THF (0.6 
M with respect to the lithium halide) were added to a separate vial.  The Schlenk flask and vial 
were sealed, removed from the glovebox, and placed under an argon atmosphere.  The copper (I) 
halide suspension was cooled to -78 C.  The lithium halide solution was cannula transferred into 
the Schlenk flask.  The mixture was stirred at -78  C for 30 minutes and then stirred at 23 oC for 
30 minutes.  The resulting cuprate solution was cooled to 0   C.  A solution of enantioenriched 
mesylate (1 eq) in THF (0.3 M with respect to the mesylate) was added dropwise via cannula to 
the cuprate solution.  The reaction proceeded with stirring at reflux for 1 hr 45 minutes.  After 
cooling the resulting mixture to 23 oC, the solution was transferred to a separatory funnel 
containing 1:1 NH4Cl (sat. aq.):NH4OH (14.8 M) and shaken.  The layers were separated.  The 
aqueous layer was extracted with Et2O.  The combined organic layers were washed with brine, 
dried over magnesium sulfate, filtered, and concentrated in vacuo to afford the crude haloallene. 
This oil was purified via flash chromatography on silica gel (100% petroleum ether) to afford 
haloallenes 12a-e as oils. 
 
 
 
 
 
 
 
 
 
(R)-1-chloro-4,4-dimethyl-1,2-pentadiene, (R)-2.12a.3    The general procedure was followed 
using CuCl (1.37 g, 13.9 mmol) in THF (2 mL), LiCl (0.30 g, 6.9 mmol) in THF (11 mL) and 
(S)-4,4-dimethylpent-1-yn-3-yl methanesulfonate (0.66 g, 3.5 mmol, 99:1 e.r.) in THF (11 mL). 
The work up used NH4Cl:NH4OH (150 mL), Et2O (2 x 125 mL), and brine (15 mL).  Flash 
chromatography (100% petroleum ether) gave chloroallene (R)-2.12a as a clear, pale yellow oil 
(0.075 g, 17%). 
 
TLC (petroleum ether) 
Rf = 0.72, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.05 (d, J = 5.5 Hz, 1H), 5.61 (d, J = 5.5 Hz, 1H), 1.09 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 199.5, 113.3, 89.3, 33.0, 29.5 
 
HRMS (EI+) 
Calculated for C7H11Cl:         130.0549 
 
 
8 Fang, L. Y.; Kauffman, G.B. Inorganic Syntheses 1983, 22, 101. 
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Found: 130.0543 
 
D  -139.8 (c 0.9, CHCl3) 
 
The e.r. was determined by chiral GC using a Cyclodex B column: 
tr (major) 2.0 min, tr (minor) 2.2 min; temperature: 80 °C; 6.5 mL/min.: 93.9:6.1 e.r. 
 
 
 
 
 
(R)-1-bromo-4,4-dimethyl-1,2-pentadiene, (R)-2.12b.3    The general procedure was followed 
using CuBr (1.92 g, 13.3 mmol) in THF (2 mL), LiBr (0.58 g, 6.7 mmol) in THF (11 mL) and 
(S)-4,4-dimethylpent-1-yn-3-yl methanesulfonate (0.64 g, 3.3 mmol, 99:1 e.r.) in THF (11 mL). 
The work up used NH4Cl:NH4OH (150 mL), Et2O (2 x 125 mL), and brine (15 mL).  Flash 
chromatography (100% petroleum ether) gave bromoallene (R)-2.12b as  a clear, yellow oil 
(0.080 g, 14%). 
 
TLC (petroleum ether) 
Rf = 0.69, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.98 (d, J = 5.5 Hz, 1H), 5.36 (d, J = 5.5 Hz, 1H), 1.09 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 199.6, 112.7, 73.1, 32.5, 29.6 
 
HRMS (EI+) 
Calculated for C7H11Br:         174.0044 
Found:                                    174.0039 
 
D   -183.0 (c 1.0, CHCl3) 
 
The e.r. was determined by chiral GC using a Cyclodex B column: 
tr (major) 3.2 min, tr (minor) 3.6 min; temperature: 80 °C; 6.5 mL/min.: 94.2:5.8 e.r. 
 
 
 
 
 
 
 
 
 
(R)-1-iodo-4,4-dimethyl-1,2-pentadiene, (R)-2.12c.3   The general procedure was followed using 
CuI (8.03 g, 42.2 mmol) in THF (7 mL), LiI (2.86 g, 21.4 mmol) in THF (35 mL) and (S)-4,4- 
dimethylpent-1-yn-3-yl methanesulfonate (2.0 g, 10.5 mmol, 99:1 e.r.) in THF (35 mL).   The 
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work up used NH4Cl:NH4OH (400 mL), Et2O  (2 x  100 mL), and brine (100 mL). Flash 
chromatography (100% petroleum ether) gave iodoallene (R)-2.12c as a clear, yellow oil (1.98 g, 
85%). 
 
TLC (petroleum ether) 
Rf = 0.74, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.71 (d, J = 6 Hz, 1H), 5.06 (d, J = 6 Hz, 1H), 1.08 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 203.3, 107.7, 36.5, 31.8, 29.7 
 
HRMS (EI+) 
Calculated for C7H11I: 221.9906 
Found: 221.9919 
D -264.2 (c 1.8, CHCl3) 
 
The e.r. was determined by chiral GC using a Cyclodex B column: 
tr (major) 2.12 min, tr (minor) 3.0 min; temperature: 100 °C; 6.5 mL/min.: 89.5:10.5 e.r. 
 
 
 
 
 
 
 
 
 
(R)-1-iodo-4-ethyl-1,2-hexadiene, (R)-2.12d.  The general procedure was followed using CuI 
(7.48 g, 39.3 mmol) in THF (6.5 mL), LiI (2.58 g, 19.3 mmol) in THF (33 mL) and (S)-4- 
ethylhex-1-yn-3-yl methanesulfonate (1.98 g, 9.7 mmol, approximately 99:1 e.r.) in THF (33 
mL).   The work up used NH4Cl:NH4OH (400 mL), Et2O (1 x 100 mL), and brine (100 mL). 
Flash chromatography (100% petroleum ether) gave iodoallene (R)-2.12d as a clear, yellow oil 
(2.7 g, 91%). 
 
TLC (petroleum ether) 
Rf = 0.71, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.67 (dd, J = 6, 1.5 Hz, 1H), 4.95 (dd, J = 8, 6 Hz, 1H), 2.03 – 1.96 (m, 1H), 1.57 – 
1.43 (m, 2H), 1.41 – 1.29 (m, 2H), 0.92 (t, J = 7.5 Hz, 3H), 0.90 (t, J = 7.5 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 205.0, 100.1, 42.0, 35.7, 27.4, 27.1, 11.7, 11.5 
 
HRMS (EI+) 
Calculated for C8H13I:            236.0062 
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Found: 236.0048 
 
D   -309.2 (c 0.9, CHCl3) 
Absolute stereochemical assignment was made according to the Lowe-Brewster rules9  and by 
analogy to known haloallenes 2.12a-c.3 
 
The ee was determined by chiral GC using a Cyclodex B column: 
tr (major) 4.2 min, tr (minor) 4.6 min; temperature: 110 °C; 6.5 mL/min.: 91.0:9.0 e.r. 
 
 
 
 
 
 
 
 
 
(R)-1-iodo-1,2-octadiene, (R)-2.12e.3    The general procedure was followed using CuI (5.59 g, 
29.4 mmol) in THF (5 mL), LiI (1.97 g, 14.7 mmol) in THF (25 mL) and (S)-oct-1-yn-3-yl 
methanesulfonate (1.50 g, 7.3 mmol, approximately 97:13 e.r.) in THF (12.5 mL).  The work up 
used NH4Cl:NH4OH (300 mL), Et2O (2 x 125 mL), and brine (30 mL).  Flash chromatography 
(100% petroleum ether) gave iodoallene (R)-2.12e as a clear, yellow oil (1.24 g, 74%). 
 
TLC (petroleum ether) 
Rf = 0.63, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.68 (ddd, J = 5.5, 2.5, 2.5 Hz, 1H), 5.11 (dt, J = 7, 6 Hz, 1H), 2.19 – 2.06 (m, 2H), 
1.54 – 1.35 (m, 2H), 1.34 – 1.27 (m, 4H), 0.91 – 0.90 (m, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 205.4, 96.5, 35.5, 31.2, 28.1, 27.5, 22.4, 14.0 
 
HRMS (EI+) 
Calculated for C8H13I:            236.0062 
Found:                                    236.0045 
 
 
-166.9 (c 1.6, CHCl3) 
 
 
The e.r. was determined by chiral GC using a Cyclodex B column: 
tr (major) 5.6 min, tr (minor) 6.2 min; temperature: 110 °C; 6.5 mL/min: 69.8:30.2 e.r. 
 
 
 
 
 
 
 
 
9 Maehr, H. Tetrahedron: Asymmetry 1992, 3, 735. 
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CHAPTER 3 
 
PROGRESS TOWARDS THE SYNTHESIS OF TWO PERIDININ DERIVATIVES 
 
3-1 BACKGROUND 
Several derivatives of peridinin have been studied in the context of their light-harvesting 
capabilities. These studies have used spectroscopic techniques to illuminate the electronic states 
that are important in light harvesting and to examine some of the structure-function relationships. 
One of the major techniques used in these studies is Stark spectroscopy, a method that shows the 
change in spectral properties of a system under an applied electric field. This allows the change 
in dipole moment to be calculated. The change in dipole moment is an indication of how well a 
given compound can function as a light-harvester. Higher changes in dipole moment are 
associated with greater light-harvesting capacity. The Katsumura group has pursued the synthesis 
of several peridinin derivatives, which have been studied in the context of their photosynthetic 
activity,1 but not their ability to quench 1O2.  For example, a series of allene-modified peridinin 
derivatives was tested using Stark spectroscopy.2 It was found that peridinin had the greatest 
change in dipole moment. Studies of other derivatives have had the same result, with peridinin 
having the greatest change in dipole moment and likely the greatest light-harvesting ability. 
These results, along with peridinin’s unique structure, raised the question of peridinin’s 
evolutionary history. We wondered for what reason Nature had evolved peridinin and whether its 
light-harvesting role or photoprotective ability took precedence. By examining peridinin and its 
derivatives in assays that evaluate their individual light-harvesting and photoprotective abilities, 
we can determine what trade-offs were made in peridinin’s evolution and apply this knowledge 
to current problems. For example, if peridinin was optimized to harvest light and not be a 
photoprotectant, learning which tailoring enzymes are responsible for this will help us to make 
synthetic carotenoids that are better than peridinin at quenching high energy species like singlet 
oxygen and triplet chlorophyll. 
Using the iterative cross-coupling strategy developed in our group,3  we proposed to 
 
synthesize a series of derivatives that each represents the reversal of a single tailoring enzyme 
modification. Although the previous work in the field often focused on derivatives where more 
than one part of the molecule was changed, the highly flexible, modular, and stereocontrolled 
synthesis of peridinin developed in out lab enables these individual reversals without affecting 
other parts of the molecule. This should allow us to pinpoint the structural reasons for peridinin’s 
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mechanism of action. The butenolide and allene functionalities are thought to be important for 
the formation of the ICT state that has been implicated as an important contributor to peridinin’s 
light harvesting capabilities, and thus were our first targets. 
 
3-2 EFFORTS TOWARDS SYNTHESIS OF ALLENE-LACKING DERIVATIVE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Retrosynthetic analysis of derivative 3.1, which lacks the allene functionality. 
 
The synthesis of derivative 3.1 was initially pursued.  Using the building block based 
synthesis of peridinin developed earlier in our group, we retrosynthesized the derivative lacking 
the  allene  into  four  building  blocks,  with  vinyl  iodide  3.3  being  the  only  previously 
unsynthesized building block. Treatment of MIDA boronate 3.25  with NaOH and I2  gave vinyl 
iodide  3.4,  which  was  subjected  to  TBAF  deprotection  followed  by  acylation  to  give  3.3 
(Scheme 6).  Heptaenyl MIDA boronate 3.5 was synthesized in the same manner as in the 
synthesis of peridinin and underwent in situ MIDA hydrolysis followed by coupling with 3.6 to 
give 3.7, protected derivative 3.1. 
 
 
 
 
 
 
 
 
Scheme 3.1. Synthesis of alternate endgroup from MIDA boronate 3.2. 
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Scheme 3.2. In situ MIDA deprotection followed by coupling to give derivative 3.1. 
 
 
 
3-3 SYNTHESIS OF BUTENOLIDE-LACKING DERIVATIVE 
 
Initial Retrosynthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Retrosynthetic analysis of derivative 3.8. 
 
The derivative lacking the butenolide was initially retrosynthesized into four building 
blocks, as shown in Figure 3.2. Three of the building blocks were known, leaving diene 3.9 to be 
synthesized for the first time. Efforts were first focused on the Stille coupling of vinyl iodide 3.4 
to bifunctional stannane 3.12 (Scheme 3.3). However, these efforts proved unfruitful. Similarly, 
attempts to employ the Negishi coupling also proved unsuccessful. 
 
 
 
 
Scheme 3.3. Initially proposed synthesis of diene 3.8. 
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We thought it might be possible to achieve the synthesis of the desired compound by 
switching the coupling partners and coupling a vinyl stannane4 to a bifunctional iodide building 
block. After a screen of standard Stille coupling conditions proved to be unfruitful, we turned our 
attention to the conditions employed by Baldwin.5  Although these conditions gave the desired 
product, they also resulted in the elimination of vinyl iodide 3.14 to give propynyl MIDA 
boronate. 
 
 
 
 
 
 
Scheme 3.4. Tetraenyl MIDA boronate was synthesized from stannane 3.13 in three steps. 
 
After some optimization, this problem remained. However, after reverse-phase MPLC 
chromatography, we were able to isolate the desired MIDA boronate 3.9 in 33% yield. The 
dienyl boronate was then subjected to a one-pot MIDA boronate deprotection and 
iododeborylation protocol6 to give dienyl iodide 3.15 in 79% yield. This iodide was then coupled 
to bisborylated compound 3.10 to give tetraenyl MIDA boronate 3.16. It is important to note that 
this intermediate could either be taken on to the targeted derivative or subjected to the lynchpin 
methodology developed in our lab by Seiko Fujii,7 and thus give the protected form of 
violaxanthin, peridinin’s biosynthetic precursor. 
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Revised Retrosynthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Revised retrosynthesis of derivative 3.8. 
 
 
 
Contemporaneously with the efforts towards the synthesis of 3.8 using Stille coupling, a 
new dienyl iodide building block 3.17 was synthesized by Jahnabi Roy and Eric Woerly.8  This 
development of this building block led to a revised retrosynthesis of derivative 3.8, as shown in 
Figure 3.3. To our gratification, the first coupling resulted in full conversion to the desired triene 
product. Scaling up the reaction resulted in a 91% yield of triene 3.21. Transesterification to the 
pinacol boronic ester 3.22 resulted in a 71% yield. Coupling of 3.22 with diene 3.17 gave the 
pentaenyl MIDA boronate 3.23 in 74% yield. Using the same transesterification conditions 
resulted in a 95% yield of pentaenyl pin ester 3.24.  The coupling of 3.24 with dienyl iodide 3.19 
gave heptaene 3.25 in 64% yield. In situ MIDA boronate deprotection and coupling gave fully 
protected 3.26, as demonstrated by high-resolution mass spectrometry. Deprotection with 
HF/pyridine has not yet successfully yielded derivative 3.8 (see Scheme 3.5). 
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Scheme 3.5. Efforts towards the synthesis of peridinin derivative 3.8 
 
 
 
3-4 SUMMARY 
 
The final coupling and silyl deprotection are the remaining challenges in the synthesis of 
derivative 3.8. Although the final coupling did afford some product, the reaction was not clean, 
giving a mixture of the product and as yet unidentified byproducts. In order to achieve the final 
coupling and deprotection, larger amounts of heptaene 3.25 would be required. The best way to 
approach this problem would be to build up large amount of the starting pinacol boronic ester, as 
well as diene 3.17. The couplings leading to the synthesis of 3.25 are robust, with the yields 
above being obtained from reactions that were set up outside of the glovebox, so it would not be 
difficult to build up large amounts. Running the final coupling on a larger scale would allow the 
byproducts to be characterized and hopefully lead to optimization of the reaction. Identification 
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of byproducts by LCMS may also be an effective way to ascertain what is happening in that 
reaction. 
The building-block based approach to the synthesis of peridinin derivatives has been 
further validated through the synthesis of protected forms of allene-lacking derivative 3.1 and 
butenolide-lacking derivative 3.8. Future studies will be focused on the activity of derivative 3.8 
in liposome-based assays to assess the impact that removal of the butenolide has on peridinin’s 
antilipoperoxidant abilities. Because the butenolide motif has been implicated in the ICT state 
that is crucial for peridinin’s light harvesting activity, it would also be interesting to look at the 
spectroscopic properties of the derivative, including Stark spectroscopy. Although peridinin 
derivatives have been examined for their light-harvesting role in photosynthesis, photoprotection, 
the other half of their dual role in nature, has been ignored. One way to examine this would be to 
look at the 1O2  quenching capacity of peridinin and its derivatives in the 1O2 quenching assay 
previously reported by Mukai and coworkers.9 
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3-6 EXPERIMENTAL INFORMATION 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa 
Aesar, TCI America, Strem Chemicals Inc., or Frontier Scientific and were used without further 
purification unless otherwise noted. Solvents were purified via passage through packed columns 
as described by Pangborn and coworkers10  (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; 
hexane, benzene, and toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves). All water was deionized prior to use. Triethylamine, diisopropylamine, 
pyridine, and 2,6-lutidine were freshly distilled under an atmosphere of nitrogen from CaH2. The 
following compounds were prepared according to known literature procedures: haloallenes 12,11 
tetraenyl pinacol boronic ester 14 and trienyl iodide 15.12    Isoprenyl MIDA boronate 9 is 
commercially available from Sigma-Aldrich (product number 707252). 
 
General Experimental Procedures. Unless noted, all reactions were performed in flame-dried 
round bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of 
argon or nitrogen. Organic solutions were concentrated via rotary evaporation under reduced 
pressure with a bath temperature of 35 – 40 oC.  Reactions were monitored by analytical thin 
layer chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 nm) 
and/or a solution of basic KMnO4 followed by brief heating using a Varitemp heat gun.  MIDA 
boronates are compatible with standard silica gel chromatography, including standard loading 
techniques.  Column chromatography was performed using standard methods13 or on a Teledyne- 
Isco CombiFlash Rf purification system using Merck silica gel grade 9385 60Å (230-400 mesh). 
For loading, compounds were adsorbed onto non acid-washed Celite in vacuo from an acetone 
solution.   Specifically, for a 1 g mixture of crude material the sample is dissolved in reagent 
grade acetone (25 to 50 mL) and to the flask is added Celite 454 Filter Aid (5 to 15 g). The 
mixture is then concentrated in vacuo to afford a powder, which is then loaded on top of a silica 
gel column. The procedure is typically repeated with a small amount of acetone (5 mL) and 
Celite (2 g) to ensure quantitative transfer. 
 
Structural analysis. 1H NMR spectra were recorded at 23 °C on one of the following 
instruments: Varian Unity 400, Varian Unity 500, Varian Unity Inova 500NB. Chemical shifts 
(δ) are reported in parts per million (ppm) downfield from tetramethylsilane and referenced to 
residual protium in the NMR solvent (CHCl3, δ = 7.26; acetone-d6, δ = 2.05, center line) or to 
added tetramethylsilane (δ = 0.00). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sext = sextet, sept = septet, m = 
multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), and integration. 13C 
NMR spectra were recorded at 23 °C on a Varian Unity 400 or Varian Unity 500. Chemical 
shifts  (δ)  are  reported  in  ppm  downfield  from  tetramethylsilane  and  referenced  to  carbon 
resonances in the NMR solvent (CDCl3, δ = 77.0, center line; center line; acetone-d6, δ = 29.80, 
center line). High resolution mass spectra (HRMS) were performed by Furong Sun and Beth 
Eves at the University of Illinois School of Chemical Sciences Mass Spectrometry Laboratory. 
 
 
 
10 Pangborn, A.B.; Giardello, M.A; Grubbs, R.H.; Rosen, R.K.; Timmers, F.J. Organometallics 1996, 15, 1518. 
11 Elsevier, C.J.; Vermeer, P.; Gedanken, A.; Runge, W. J. Org. Chem. 1985, 50, 364. 
12 Furuichi, N.; Hara, H.; Osaki, T.; Nakano, M.; Mori, H.; Katsumura, S. J. Org. Chem. 2004, 69, 7949. 
13 Still, W.C.; Kahn, M.; Mitra, A.; J. Org. Chem. 1978, 43, 2923. 
30  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vinyl iodide 3.4.  To a 7-mL vial charged with 0.100 g (0.22 mmol) MIDA boronate 3.2 was 
added1.1 mL THF and 0.4 mL aqueous 3 M NaOH (1.2 mmol, 5 eq).  The reaction stirred 
vigorously at rt for 10 min.  It was cooled to 0 C and a solution of 0.022 g I2 in 1.3 mL THF was 
added dropwise via cannula.  The reaction was stirred at 0 C for 30 min and then was quenched 
with Na2S2O3 (2 mL) and diluted with Et2O (5 mL).  The layers were separated and the aqueous 
layer was extracted with Et2O (2 x 10 mL) and the combined organic layers were dried over 
Na2SO4 and concentrated.  The residue was pushed through a plug of silica gel with Et2O to give 
the product as a pale yellow oil (0.070 g, 75%) 
 
 
 
 
 
 
 
 
 
 
 
Vinyl iodide 3.5.  To a 7-mL vial equipped with stir bar and charged with 3.4 was added THF 
(0.3 mL) and TBAF (1.0 M in THF, 0.33 mL, 0.33 mmol, 2 eq).  The reaction stirred at 23 C for 
4 hours. NaHCO3  (1 mL) was added and the mixture was diluted with Et2O (3 mL). The 
aqueous layer was separated and extracted with Et2O (3 x 5 mL).  The combined organic layers 
were dried (MgSO4) and concentrated in vacuo. The product was used in the next reaction 
without further purification. 
 
 
 
 
 
 
 
 
Vinyl iodide 3.3.  To a 7-mL vial charged with vinyl iodide 3.5 was added Ac2O (0.08 mL, 5 eq) 
and 0.5 mL freshly distilled pyridine.  The reaction was left to stir at 23 C for 14 hours.  The 
reaction mixture was diluted with Et2O (4 mL) and saturated aqueous CuSO4 (2 mL) was added. 
The organic layer was separated, washed with CuSO4 (1 mL), dried over MgSO4 and 
concentrated.   The residue was adsorbed onto Celite and purified by column chromatography 
(SiO2) to give the product as a pale yellow oil (0.019 g, 34%).  Spectral properties matched those 
previously reported in the literature.14 
 
 
 
 
14 Kajikawa, T.; Aoki, K.; Singh, R.S.; Iwashita, T.; Kusumoto, T.; Frank, H.A.; Hashimoto, H.; Katsumura, S., Org. Biomol. 
Chem., 2009, 7, 3723 
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Protected derivative 3.7. 
Preparation of catalyst stock solution. In a glovebox, to a 7 mL vial equipped with a stir bar and 
charged with XPhos  (8.1 mg, 0.017 mmol) and Pd(OAc)2 (1.9 mg, 0.008 mmol) was added THF 
(degassed, inhibited with 250 ppm BHT, 1.0 mL). The solution was stirred at 23 °C for 10 min to 
afford a clear, brown solution. 
 
The freshly prepared catalyst stock solution was used in the following reaction: 
In a glovebox, to a 2 mL vial equipped with a stir bar and charged with MIDA boronate 3.6 (11.3 
mg, 0.017 mmol) was added finely ground NaOH (18.7 mg, 0.47 mmol).  Vinyl iodide 3.3 (10.7 
mg, 0.031 mmol) was added as a solution in THF (degassed, inhibited with 250 ppm BHT, 0.54 
mL).   A portion of the prepared catalyst solution (0.10 mL, which contains 0.0008 mmol 
Pd(OAc)2  and 0.0017 mmol XPhos) was added in one portion.   The vial was sealed with a 
septum cap and removed from the glovebox.   Degassed DI H2O (0.11 mL) was added.   The 
solution was stirred in a subdued light environment at 23 oC for 1.5 hr.  The reaction mixture was 
poured into aqueous sodium phosphate buffer (1 M, pH 7.0, 2 mL) and diluted with Et2O (4 mL). 
The mixture was shaken and the layers were separated. The aqueous phase was extracted with 
Et2O (1 x 2 mL).  The combined organic layers were dried over MgSO4, filtered, and then 
concentrated in vacuo.  The resulting residue was dry loaded onto Celite from an Et2O solution, 
and purified via reverse phase flash chromatography on C18 silica gel (H2O:Acetone 7:3 → 
0:100) to afford protected peridinin derivative 3.7 as a red solid. 
 
HRMS (ESI+) 
Calculated for C45H64O7Si:    745.4421 
Found:                                    745.4490 
 
 
 
 
 
 
 
 
 
 
MIDA boronate 3.9. 
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1H-NMR (500 MHz, d6-acetone) 
δ 6.25 (d, J = 15.6 Hz, 1H), 6.00 (d, J = 15.6 Hz, 1H), 5.39 (s, 1H), 4.21 (d, J = 16.9 Hz, 
2H), 4.06 (d, J = 19.0 Hz, 2H), 3.90 – 3.82 (m, 1H), 3.04 (s, 3H), 2.22 (ddd, J = 14.4, 5.1, 
1.8 Hz, 1H), 1.96 (s, 3H), 1.71 – 1.63 (m, 1H), 1.54 – 1.43 (m, 1H), 1.32 – 1.23 (m, 3H), 
1.15 (s, 3H), 1.14 (s, 3H), 0.93 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 
 
 
 
HRMS (ESI+) 
Calculated for  C27H44BNO6Si:          510.3109 
Found:                                                518.3094 
 
 
 
 
 
Dienyl iodide 3.15. To a 7 mL vial containing MIDA boronate 3.9 and a stir bar were added 0.03 
mL 3 M NaOH and 0.1 mL THF. The reaction was left to stir vigorously for 10 minutes and was 
then cooled to 0 C, after which time a solution of 14 mg I2 in 0.06 mL THF was added dropwise. 
The reaction was stirred at 0 C for 30 min and then was quenched with Na2S2O3  (2 mL) and 
diluted with Et2O (5 mL).  The layers were separated and the aqueous layer was extracted with 
Et2O (2 x 10 mL) and the combined organic layers were dried over Na2SO4  and concentrated. 
The residue was pushed through a plug of silica gel with Et2O to give the product as a pale 
yellow oil (6.5 mg, 77%). 
 
1H-NMR (500 MHz, d6-acetone) 
δ 6.54 (d, J = 1.2 Hz, 1H), 6.34 (d, J = 15.5 Hz, 1H), 6.14 (d, J = 15.5 Hz, 1H), 3.92 – 
3.84 (m, 1H), 2.26 – 2.19 (m, 1H), 1.71 – 1.63 (m, 1H), 1.54 – 1.48 (m, 1H), 1.37 (dd, J 
= 14.8, 7.3 Hz, 1H), 1.16 (s, 3H), 1.13 (s, 3H), 0.92 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 
0.06 (s, 3H). 
 
 
 
 
 
 
 
 
MIDA boronate 3.16. In the glovebox, to a 7 mL vial containing dienyl iodide 3.15 (6.0 mg, 
0.013 mmol) and bifunctional diene 3.11 (3.5 mg, 0.010 mmol) were added K3PO4  (12.7 mg, 
0.060 mmol) and PdCl2(dppf) DCM (0.41 mg, 0.0004 mmol), followed by DMSO (0.2 mL). 
The vial was removed from the glovebox and placed in a 45  C heating block and left to stir for 
12 hours. It was cooled to rt and diluted with EtOAc and then washed with water. The organic 
layer was dried and concentrated. Purification by pipet column (SiO2, Et2O:MeCN 100:0  
60:40) afforded the product as an orange solid (3.9 mg, 70%). 
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1H-NMR (500 MHz, d6-acetone) 
δ 6.67 (dd, J = 15.1, 11.2 Hz, 1H), 6.41 (d, J = 15.2 Hz, 1H), 6.27 (d, J = 15.6 Hz, 1H), 
6.19 (d, J = 10.4 Hz, 1H), 6.03 (d, J = 15.5 Hz, 1H), 5.46 (s, 1H), 4.22 (d, J = 16.9 Hz, 
2H), 4.05 (d, J = 18.4 Hz, 2H), 3.94 – 3.82 (m, 1H), 3.03 (d, J = 3.8 Hz, 3H), 2.23 (ddd, J 
= 14.3, 5.1, 1.7 Hz, 1H), 2.01 (s, 3H), 1.95 (s, 3H), 1.71 – 1.64 (m, 1H), 1.52 (ddd, J = 
13.0, 3.3, 1.7 Hz, 1H), 1.41 – 1.31 (m, 1H), 1.17 (d, J = 1.2 Hz, 3H), 1.14 (s, 3H), 0.94 (s, 
3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 
 
 
 
 
 
 
 
 
MIDA boronate 3.21. To a 20 mL Ichem vial containing a stir bar, pinacol boronic ester 3.18 
(289.8 mg, 0.688 mmol)  and iodide 3.16 (200 mg, 0.573 mmol) were added Cs2CO3 (749 mg, 
2.30  mmol)  and  2nd  generation  XPhos  palladacycle  (68  mg,  0.086  mmol).  The  vial  was 
evacuated and backfilled with nitrogen. DMSO (11.5 mL) was added and the vial was placed in a 
35 ºC  aluminum heating block and left to stir at that temperature for 21 hours. The vial was then 
removed from the heating block and allowed to cool to room temperature. The reaction mixture 
was poured into a separatory funnel containing EtOAc and 20 mL deionized water. The aqueous 
layer was removed and the organic layer was washed with water (2 x 10 mL). The combined 
aqueous layers were extracted with EtOAc (2 x 20 mL), dried over MgSO4, filtered, and 
concentrated. The resulting residue was adsorbed onto Celite from an acetone solution and 
purified using Florisil (Et2O:MeCN 100:0 60:40) to give 270 mg (91%) of a yellow-orange 
solid. 
 
 
 
 
1H-NMR (500 MHz, d6-acetone) 
δ  6.97 (dd, J = 17.2, 11.0 Hz, 1H), 6.24 (d, J = 15.5 Hz, 1H), 6.16 (d, J = 11.0 Hz, 1H), 
6.07 (d, J = 15.5 Hz, 1H), 5.76 (d, J = 17.2 Hz, 1H), 4.22 (d, J = 16.9 Hz, 2H), 4.04 (d, J 
= 16.9 Hz, 2H), 3.94 – 3.85 (m, 1H), 3.01 (s, 3H), 2.23 (ddd, J = 14.4, 5.1, 1.7 Hz, 1H), 
1.92 (s, 3H), 1.71 – 1.63 (m, 1H), 1.52 (ddd, J = 13.0, 3.3, 1.8 Hz, 1H), 1.35 – 1.23 (m, 
1H), 1.16 (s, 3H), 1.14 (s, 3H), 0.93 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 
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13C-NMR (125 MHz, d6-acetone) 
δ 168.41, 138.47, 137.10, 134.90, 133.40, 125.87, 70.01, 66.50, 65.00, 61.69, 47.29, 
46.77, 41.54, 35.15, 29.14, 25.62, 25.59, 24.81, 19.71, 17.98, -5.12, -5.15 
 
 
 
HRMS (ESI+) 
Calculated for  C27H44BNO6Si: 518.3109 
Found: 518.3094 
 
 
 
 
 
 
 
 
Pinacol ester 3.22. To a 20 mL vial containing MIDA boronate 3.21 (270 mg, 0.520 mmol) and 
a stir bar were added pinacol (94 mg, 0.795 mmol) and NaHCO3 (221 mg, 2.63 mmol). The vial 
was placed under nitrogen and 5.2 mL MeOH was added. The vial was placed in a 40 ºC heating 
block and left to stir for 2 hours. The vial was allowed to cool to room temperature and the 
mixture was filtered through Celite, rinsing with ethyl acetate. The solution was concentrated 
and azeotroped with toluene. Then, NaHCO3 (222 mg, 2.64 mmol) and CaCl2 (58 mg, 0.523 
mmol) were added. The mixture was left to stir at rt for 16 hours. The mixture was filtered as 
before and concentrated to give 189 mg (71%) pinacol boronic ester 3.22. 
 
 
 
 
 
 
 
 
1H-NMR (500 MHz, d6-acetone) 
δ 7.35 (dd, J = 17.3, 11.2 Hz, 1H), 6.28 (d, J = 15.5 Hz, 1H), 6.20 (s, 1H), 6.16 (d, J = 
15.6 Hz, 1H), 5.58 (d, J = 17.3 Hz, 1H), 3.90 (s, 1H), 2.31 (s, 1H), 2.24 (ddd, J = 14.4, 
5.1, 1.7 Hz, 1H), 1.72 – 1.64 (m, 1H), 1.58 – 1.45 (m, 1H), 1.30 (s, 3H), 1.25 (s, 12H), 
1.18 (s, 3H), 1.14 (s, 3H), 0.94 (s, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
 
13C-NMR (125 MHz, d6-acetone) 
δ 146.25, 137.83, 133.86, 130.08, 129.35, 128.38, 84.05, 70.94, 65.95, 48.25, 42.51, 
36.14, 30.15, 26.65, 26.62, 25.86, 25.65, 25.50, 20.75, 18.98, -4.08, -4.11 
 
HRMS (ESI) 
Calculated for C28H49BO4Si: 489.3571 
Found: 489.3564 
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MIDA boronate 3.23. To a 20 mL Ichem vial containing a stir bar, pinacol boronic ester 3.22 
(189 mg, 0.386 mmol) and iodide 3.16 (111.6 mg, 0.321 mmol) were added Cs2CO3  (430 mg, 
1.31  mmol)  and  2nd  generation  XPhos  palladacycle  (39  mg,  0.050  mmol).  The  vial  was 
evacuated and backfilled with nitrogen. DMSO (5.5 mL) was added and the vial was placed in a 
35 ºC  aluminum heating block and left to stir at that temperature for 15 hours. The vial was then 
removed from the heating block and allowed to cool to room temperature. The reaction mixture 
was poured into a separatory funnel containing 20 mL EtOAc and 15 mL deionized water. The 
aqueous layer was removed and the organic layer was washed with water (2 x 10 mL). The 
combined aqueous layers were extracted with EtOAc (2 x 20 mL), dried over MgSO4, filtered, 
and concentrated. The resulting residue was adsorbed onto Celite from an acetone solution and 
purified using Florisil chromatography (Et2O:MeCN 100:0 60:30) to give 140  mg (74 %) of a 
red-orange solid. 
 
 
 
 
 
 
 
1H-NMR (500 MHz, d6-acetone) 
δ  7.06 – 6.95 (m, 1H), 6.73 (dd, J = 15.1, 11.3 Hz, 1H), 6.41 (d, J = 15.1 Hz, 1H), 6.27 
(d, J = 15.6 Hz, 1H), 6.25 – 6.18 (m, 2H), 6.02 (d, J = 15.5 Hz, 1H), 5.77 (d, J = 17.1 Hz, 
1H), 4.22 (d, J = 16.9 Hz, 2H), 4.04 (d, J = 17.0 Hz, 2H), 2.99 (s, 3H), 2.23 (ddd, J = 
14.3, 5.0, 1.7 Hz, 1H), 1.97 (s, 3H), 1.94(m, 3H), 1.67 (dd, J = 14.3, 8.2 Hz, 1H), 1.52 
(ddd, J = 13.0, 3.4, 1.8 Hz, 1H), 1.16 (s, 3H), 1.14 (s, 3H), 0.94 (s, 3H), 0.89 (d, J = 4.2 
Hz, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 
 
13C-NMR (125 MHz, d6-acetone) 
δ  169.19, 139.24, 138.87, 137.86, 137.07, 135.35, 134.79, 132.70, 126.25, 125.73, 70.73, 
67.20, 65.66, 62.39, 47.94, 47.49, 42.21, 41.34, 35.84, 26.32, 26.29, 25.56, 20.45, 18.65, 
13.15, 12.99, -4.41, -4.43 
 
HRMS (EI+) 
Calculated for  C32H50BNO6Si: 584.3579 
Found: 584.3582 
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Pinacol ester 3.24. To a 20 mL vial containing MIDA boronate 3.23 (139 mg, 0.238 mmol) and 
a stir bar were added pinacol (46 mg, 0.389 mmol) and NaHCO3 (100.5 mg, 1.19 mmol). The 
vial was placed under nitrogen and 2.4 mL MeOH was added. The vial was placed in a 40 ºC 
heating block and left to stir for 2.5 hours. The vial was allowed to cool to room temperature and 
the mixture was filtered through Celite, rinsing with ethyl acetate. The solution was concentrated 
and azeotroped with toluene. Then, NaHCO3 (111 mg, 1.32 mmol) and CaCl2 (134 mg, 1.21 
mmol) were added. The mixture was left to stir at rt for 1.5 hours. The mixture was filtered as 
before and concentrated to give 127 mg (95%) pinacol boronic ester 3.24. 
 
 
 
 
 
 
 
 
1H-NMR (500 MHz, d6-acetone) 
δ 7.37 (dd, J = 13.0, 11.4 Hz, 1H), 6.87 – 6.77 (m, 1H), 6.44 (t, J = 12.4 Hz, 1H), 6.36 – 
6.26 (m, 1H), 6.23 (m, 2H), 6.06 (d, J = 15.5 Hz, 1H), 5.57 (d, J = 17.3 Hz, 1H), 3.93 – 
3.83 (m, 1H), 2.01 (s, 3H), 1.96 (d, J = 6.3 Hz, 3H), 1.68 (dd, J = 14.4, 8.2 Hz, 1H), 1.59 
– 1.48 (m, 1H), 1.34 – 1.26 (m, 2H), 1.25 (s, 12H), 1.14 (d, J = 4.1 Hz, 6H), 0.99 – 0.93 
(m, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 
 
 
 
13C-NMR (125 MHz, d6-acetone) 
δ 169.20, 139.24, 138.88, 137.87, 137.08, 135.35, 134.79, 132.71, 126.25, 125.73, 70.74, 
67.20, 65.66, 62.39, 47.94, 47.49, 42.22, 41.35, 35.84, 29.86, 26.32, 26.29, 25.56, 20.45, 
18.66, 13.00, -4.40, -4.43. 
 
 
 
HRMS (ESI+) 
Calculated for C33H55BO4Si: 555.4041 
Found: 555.4038 
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MIDA boronate 3.25. To a 20 mL Ichem vial containing a stir bar, pinacol boronic ester 3.24 
(127 mg, 0.229 mmol) and iodide 3.16 (67.3 mg, 0.191 mmol) were added Cs2CO3  (251 mg, 
0.770 mmol) and 2nd generation XPhos palladacycle (23.1 mg, 0.029 mmol). The vial was 
sealed, removed from the glovebox, and placed under inert atmosphere. DMSO (3.8 mL) was 
added and the vial was placed in a 35 ºC  aluminum heating block and left to stir at that 
temperature for 12 hours. The vial was then removed from the heating block and allowed to cool 
to room temperature.  The reaction mixture was poured into  a separatory funnel  containing 
EtOAc (30mL). The organic layer was washed with H2O:brine (5:1, 3 x 15mL), then dried over 
MgSO4, filtered, and concentrated. The resulting residue was adsorbed onto Celite from an 
acetone solution and purified using reverse-phase MPLC (C18, H2O:MeCN 100:0 0:100) to 
give 80 mg of a red solid. (65%) 
 
 
 
 
1H-NMR (500 MHz, d6-acetone) 
δ 6.78 – 6.63 (m, 3H), 6.54 – 6.41 (m, 4H), 6.33 – 6.20 (m, 3H), 6.02 (d, J = 15.5 Hz, 
1H), 4.23 (d, J = 17.3, 2H) 4.05 (d, J = 17.3 Hz, 2H), 3.95 – 3.83 (m, 1H), 2.96 (s, 3H), 
2.29 – 2.20 (m, 1H), 1.97 (s, 3H), 1.95 (s, 3H), 1.82 (s, 3H), 1.68 (dd, J = 14.4, 8.3 Hz, 
1H), 1.52 (ddd, J = 13.1, 3.3, 1.7 Hz, 1H), 1.32 – 1.22 (m, 1H), 1.16 (s, 3H) 1.14 (s, 3H), 
0.94 (s, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 
 
, 
13C-NMR (125 MHz, d6-acetone) 
δ  169.30,  139.02,  138.01,  137.55,  137.35,  135.38,  135.27,  133.39,  133.00,  132.07, 
130.98, 130.26, 126.02, 125.57, 70.86, 67.32, 65.78, 62.82, 48.07, 42.33, 35.96, 29.93, 
26.39, 26.36, 25.63, 20.51, 18.75, 13.22, 1.27, 1.25 -4.35, -4.37. 
 
HRMS (ESI+) 
Calculated for C37H56BNO6Si:           650.4048 
Found:                                                650.4041 
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Protected derivative 3.26 
In a glovebox, to a 2 mL vial equipped with a stir bar and charged with MIDA boronate 16 (37 
mg, 0.057 mmol) and 2nd generation XPhos palladacycle (8.1 mg, 0.010 mmol) was added finely 
ground NaOH (27.7 mg, 0.470 mmol).  Allenyl iodide 3.11 (37 mg, 0.088 mmol) was added as a 
solution in THF (degassed, inhibited with 250 ppm BHT, 1.9 mL).  The vial was sealed with a 
septum cap and removed from the glovebox.   Degassed DI H2O (0.4 mL) was added.   The 
solution was stirred in a subdued light environment at 23 oC for 30 min.  The reaction mixture 
was dried over MgSO4, filtered, and then concentrated in vacuo.  The resulting residue was dry 
loaded onto Celite from an Et2O solution, and purified via reverse phase flash chromatography 
on C18 silica gel (H2O:Acetone 100:0 → 0:100) to afford protected peridinin derivative 3.26 as a 
red solid. 
 
 
 
 
 
 
 
 
 
HRMS (ESI+) 
Calculated for C48H76O5Si2:   789.5310 
Found: 789.5313 
